HealthTree

Lymphoma Nail Changes Explained

Coping With a Rare Cancer Diagnosis

Coping With a Rare Cancer Diagnosis image

Relapsed Follicular Lymphoma: Treatment Options and What to Expect

Relapsed Follicular Lymphoma: Treatment Options and What to Expect image

Taiji & Qigong for Cancer: Restoring Balance, Strength, and Hope

Apr 14, 2026

02:00PM - 03:00PM EDT

Playlist: Starting DLBCL Treatment

What is the role of radiation therapy in the treatment of newly diagnosed DLBCL patients?

Video details & playlist

Pilates for Strength and Mobility: What People With Cancer Need to Know

Pilates for Strength and Mobility: What People With Cancer Need to Know image

Playlist: Starting DLBCL Treatment

When is it appropriate to use stem cell transplant for newly diagnosed DLBCL patients? What are the eligibility criteria?

Video details & playlist

Playlist: Bispecific Antibodies in DLBCL

When are bispecific antibodies and CAR T-cell therapy used for DLBCL, and how might that change in the future?

Video details & playlist

Health Policy 101: What You Should Know

Health Policy 101: What You Should Know image

Why Are People Dropping Red Meat?: Lowering Cancer Risk through Dietary Changes

Why Are People Dropping Red Meat?: Lowering Cancer Risk through Dietary Changes image

Strength Training for People with Cancer

Strength Training for People with Cancer image

Bi-Monthly Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Apr 07, 2026

01:00PM - 02:00PM EDT

Prescription Coverage and Medicare: Tips for Patients and Caregivers

Prescription Coverage and Medicare: Tips for Patients and Caregivers image

Support HealthTree's Mission

Playlist: Basic Genetics and Cancer Tumor Biology-Updated

Read Page

How is DNA structured? What are bases? What is a sequence?

Video details & playlist

Can Side Effect Risk Be Predicted for LBCL CAR-T and Bispecific Antibodies?

Can Side Effect Risk Be Predicted for LBCL CAR-T and Bispecific Antibodies? image

Predicting the Risk of Lymphoma Relapse: Latest Research

Predicting the Risk of Lymphoma Relapse: Latest Research image

Axi-cel vs Liso-cel CAR T-cell Therapy as Second LBCL Treatments

Axi-cel vs Liso-cel CAR T-cell Therapy as Second LBCL Treatments image

azureAnemone

General Discussion • March 26

M-Spike % is rising

My M-Spike % a few months back began to rise from 0 beginning at: 2.7%, then 3.5, 4, 4.2, & currently at 5.3%. I'm on Dara once per month injection only. I immediately contacted my Doctor who advised me to continue thru my 6 month therapy regimen, & then meet in April. Is 5.3% considered alarmingly high? Also, how do you go about discussing changes in therapy? I've had a Stem Cell Transplant in 2021 that didn't reduce the cancer. Any advice would be greatly appreciated. Ken

Setting Health Goals During Blood Cancer Treatment: Safe Movement & Strength

Mar 26, 2026

03:30PM - 04:30PM EDT

Living with Cancer: Lessons From Jason Mook’s Unshaken Story

Living with Cancer: Lessons From Jason Mook’s Unshaken Story image

Tafasitamab with Lenalidomide and Rituximab for Relapsed Follicular Lymphoma

Tafasitamab with Lenalidomide and Rituximab for Relapsed Follicular Lymphoma image